A Comparison of LASIK Versus PRK Enhancement Outcomes in Eye With Prior Cataract Surgery.

医学 激光手术 角膜磨镶术 光折变性角膜切除术 正视 眼科 激光矫视 白内障手术 视力 准分子激光器 折射误差 验光服务 角膜 激光器 光学 物理
作者
Derek Rohlf
出处
期刊:PubMed 卷期号:76 (9): 402-402
链接
标识
摘要

Cataract surgery continues to evolve with increasing levels of precision through the development and introduction of new technologies. Despite these advances, unexpected visual outcomes attributable to residual refractive error still occur. Additional "enhancement" procedures to the cornea can treat this residual refractive error to achieve a satisfactory outcome. Two frequently employed excimer laser enhancement procedures include laser in-situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). While both of these procedures are widely accepted as safe and effective in treating refractive error, there is a paucity of data comparing the two as enhancements in the post-cataract population. The purpose of this study was to investigate visual and refractive parameters in the pre- and post-enhancement setting on post-cataract surgery patients to compare the effectiveness of both excimer laser-enhancement treatments.This study examined patients that underwent post-cataract extraction excimer laser enhancement surgery targeted for emmetropia (±0.50 D). The setting was a private, tertiary surgery center. Refractive enhancement procedures were performed by 3 different surgeons. Post-enhancement uncorrected distance visual acuity (UDVA) and manifest refraction spherical equivalent (MRSE) was recorded for all available follow-ups and compared for both groups.This study included 822 post-cataract enhanced eyes (491 LASIK; 331 PRK). For patients with at least six months follow up, mean UDVA was 0.05 ± 0.13 logMAR in LASIK-enhanced patients and 0.15 ± 0.20 in PRKenhanced patients. Mean absolute value MRSE was 0.22 ± 0.36 and 0.48 ± 0.62 for LASIK- and PRKenhanced patients at or beyond six months, respectively. A total of 330 (67%) of LASIK-enhanced patients achieved 20/20 or better post-enhancement UDVA, compared to 142 (43%) PRK-enhanced patients. Categorized by pre-enhancement UDVA, LASIK-enhanced patients showed significantly better post-enhancement UDVA than PRK-enhanced patients, except in those with pre-enhancement vision of 20/20 or better, or those worse than 20/50. LASIK-enhanced virgin corneas had mean post-enhancement of 0.05 ± 0.14 UDVA compared to 0.13 ± 0.19 UDVA in PRK-enhanced virgin cornea patients.LASIK provides better and more predictable outcomes in UDVA than PRK in post-cataract enhancement patients, even when categorizing patients by their pre-enhancement visual acuity, prior ocular procedures, and allowing for sufficient time for healing and stabilization of the cornea.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
万能图书馆应助逸晨采纳,获得10
刚刚
刚刚
星辰大海应助gdh采纳,获得10
刚刚
刚刚
简单的迎彤完成签到,获得积分10
1秒前
SHIKI发布了新的文献求助10
2秒前
YYY发布了新的文献求助10
3秒前
chen完成签到,获得积分10
3秒前
88发布了新的文献求助10
3秒前
SL发布了新的文献求助10
4秒前
爱学习的老中医完成签到,获得积分10
5秒前
7秒前
perry发布了新的文献求助10
10秒前
杨洁完成签到,获得积分10
11秒前
11秒前
12秒前
12秒前
旎旎关注了科研通微信公众号
13秒前
科研通AI2S应助Reset采纳,获得10
13秒前
免疫与代谢研究完成签到,获得积分10
13秒前
13秒前
14秒前
土豪的书蝶完成签到,获得积分10
15秒前
Owen应助小小酥采纳,获得10
15秒前
易达发布了新的文献求助30
16秒前
Singularity应助小白采纳,获得10
16秒前
16秒前
chen发布了新的文献求助10
16秒前
gchfv发布了新的文献求助30
17秒前
17秒前
YYY完成签到,获得积分20
18秒前
科研通AI2S应助ice采纳,获得10
19秒前
less12323完成签到,获得积分10
19秒前
19秒前
20秒前
21秒前
21秒前
糕糕完成签到,获得积分10
23秒前
23秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146046
求助须知:如何正确求助?哪些是违规求助? 2797450
关于积分的说明 7824222
捐赠科研通 2453810
什么是DOI,文献DOI怎么找? 1305876
科研通“疑难数据库(出版商)”最低求助积分说明 627593
版权声明 601491